Children’s Health Choices

Making Smarter Decisions

SahmAdrangi’s Excellence in Providing Investment Opportunities at Kerrisdale Capital Management

October 14, 2017 by Posted in: BUsinessmanSahmAdrangi

SahmAdrangi founded Kerrisdale Capital Management in 2009, and he is currently the Chief Investment Officer. He got his doctorate in Bachelor of Arts in Economics from Yale University and has been faithful to the services he has been offering the company to ensure that everything they partake of is a success. In connection to this, SahmAdrangi has focused his efforts in perfecting service provision in the various sectors within the firm with an example being the biotechnology department. Here he has fuelled the publishing of research about Sage Therapeutics, Pulse Biosciences, and many others. Other sectors of interest have been the mining and telecommunication departments.

As a young entrepreneur, he started working at Deutsche Bank and later worked with the Chanin Capital Partners. Working with these financial institutions gained him a lot of experience which earned him a position at Longrace Management, a multi-billion dollar investment company. He has shared his knowledge and experience with other investors by giving speeches during business conferences such as Activist Investor Conference, Value Investing Conference and many others. By being given a chance to address such great conferences, it is evident that he is an influential entrepreneur who dictates a lot of change in the industry.

Due to his excellence in the finance businesses, he has attracted many media houses who has conducted interviews with him. The information from these interviews has therefore been published in journals and newsletters such as BusinessWeek and Washington Post which have positively impacted on its readers. The company has managed to raise large volumes of hedge funds within a short period due to his astounding leadership skills. These funds would be used by the company’s financial analysts in purchasing stocks which would bring the company’s name into the limelight.

Kerrisdale can now manage over five hundred million dollars compared to their previous financial years. Their hedge funds have managed to give the huge returns with profits shooting with greater percentages of up to 28% over the past few years. Some of the companies where they have a major interest are those that produce medicinal drugs such as Sage Therapeutics and many others. With all these being done, the company is assured of gaining more investors hence making bigger profits.